HAVCR2 and neoplasm: In addition, the recruitment of CD3+ was found in the tumor area (Figure 7E) after Nb‐TriTE treatment, in which the proportions of CD3+/TIM3+ and CD3+/PD‐1+ cells were lower compared to the vehicle group (Figure S6, Supporting Information).